Atrial Fibrillation and VTE Dominance: Segmentation in the Apixaban...

Ajouter une nouvelle offre d'emploi Health

2025-11-25 08:26:02 -

Atrial Fibrillation and VTE Dominance: Segmentation in the Apixaban Market segment by Indication

The Apixaban Market segment structure is overwhelmingly dominated by the two primary therapeutic applications: stroke prevention in patients with atrial fibrillation (AF) and the prevention and treatment of venous thromboembolism (VTE). The AF segment represents the largest portion of the market, driven by the high and increasing global prevalence of this arrhythmia, especially within the...

0 Commentaires 0 Parts 232 Vue 0 Aperçu